Products

See leaflet See Risk Management Plan

Miasoma®
bortezomib

Indications

  • Treatment of patients with multiple myeloma.
  • Treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy.

Presentations

  • 3,5 mg x 1 frasco ampolla